SLC5A2 and hydrops fetalis: Although there is no conclusive evidence that SGLT2 inhibitors’ effects on HF involve ketone metabolism, the presence of ketones following SGLT2 inhibition may still offer therapeutic benefits for cardiovascular protection, probably due to ketones’ ability to activate nutrient deprivation signals rather than serving as a primary energy source for ATP synthesis [138].